Stocks360

Rhino Biotech Limited (RBRXF)

Stock analysis · OTC · Financial Services · Shell Companies

Share: Facebook X WhatsApp SMS
$0.00

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$3.10K
PE (TTM)
-0.17
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-0.19
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.00
Avg Volume
N/A
Volume
1.91K

Rhino Biotech Limited (RBRXF) is a publicly traded company in the Financial Services sector. Latest price: $0.00. Market cap $3.10K. Trailing PE -0.17. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Rhino Biotech Limited

Rhino Biotech Limited is dedicated to pioneering the development of health supplements sourced from plants and fungi, in addition to biopharmaceutical solutions designed for both disease prevention and treatment. The company adopted its current name, Rhino Biotech Limited, in September 2021, having previously operated as Eurasia Energy Limited. Established in 2003, its operations are based in South Hill, Anguilla.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)-0.17×
P/S (TTM)0.00×
P/B-0.06×
P/FCF (TTM)-0.19×
EV / EBITDA-2.03×
EV / Sales0.00×
Earnings Yield-614.59%
Free Cash Flow Yield-515.17%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$43.10K
Net Income (TTM)-$19.08K
Free Cash Flow (TTM)-$16.00K
Net Debt$39.99K
Working Capital-$3.05K
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Return on Equity42.73%
Return on Invested Capital695.71%

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap